By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
Alcon Manufacturing Ltd. et al. v. Barr Laboratories Inc.
1:07-cv-00718; filed November 7, 2007 in the District Court of Delaware
Infringement of U.S. Patent Nos. 5,641,805 ("Topical Ophthalmic Formulations for Treating Allergic Eye Diseases," issued June 24, 1997) and 5,116,863 ("Dibenz[b,e]oxepin Derivative and Pharmaceutical Compositions Thereof," issued May 26, 1992) following a paragraph IV certification as part of Barr's filing of an ANDA to manufacture a generic version of Alcon's Patanol® (an ophthalmic solution containing olopatadine hydrochloride, used to treat allergic conjunctivitis). View the complaint here.
Connetics Corporation et al. v. Pentech Pharmaceuticals, Inc.
1:2007cv06297; filed November 6, 2007 in the Northern District of Illinois
Infringement of U.S. Patent Nos. 6,126,920 ("Method of Treating a Skin Disease with a Corticosteroid-Containing Pharmaceutical Composition," issued October 3, 2000) and 7,078,058 ("Corticosteroid-Containing Pharmaceutical Composition," issued July 18, 2006) following a paragraph IV certification as part of Pentech's filing of an ANDA to manufacture a generic version of Connetics' Luxiq® (betamethasone valerate foam, used to treat dermatoses of the scalp). View the complaint here.
Bayer Healthcare Pharmaceuticals Inc. v. Watson Pharmaceuticals, Inc. et al.
2:07-cv-01472; filed November 5, 2007 in the District Court of Nevada
Infringement of U.S. Patent Nos. 6,787,531 ("Pharmaceutical Composition for Use as a Contraceptive," issued September 7, 2004), RE37,564 ("Composition for Contraception," issued February 26, 2002), and RE37,838 (same title, issued September 10, 2002) following a paragraph IV certification as part of Watson's filing of an ANDA to manufacture a generic version of Bayer's Yaz® (drospirenone & ethinyl estradiol, used for oral contraception). View the complaint here.
Glaxo Group Ltd. et al. v. Teva Pharmaceuticals USA Inc.
1:07-cv-00713; filed November 2, 2007 in the District Court of Delaware
Infringement of U.S. Patent No. 5,859,021 ("Antiviral Combinations," issued January 12, 1999) following a paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of Glaxo's Combivir® (lamivudine and zidovudine, used in the treatment of HIV-1 infection). View the complaint here.
Sepracor Inc. et al. v. Lupin Limited et al.
3:07-cv-05265; filed November 1, 2007 in the District Court of New Jersey
Infringement of U.S. Patent Nos. 7,214,683 ("Compositions of Descarboethoxyloratadine," issued May 8, 2007) and 7,214,684 ("Methods for the Treatment of Allergic Rhinitis," issued May 8, 2007), licensed to Schering-Plough, following a paragraph IV certification as part of Lupin's filing of an ANDA to manufacture a generic version of Schering-Plough's Clarinex® (desloratidine, used to treat allergies). View the complaint here.
Comments